Meeder Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,385
Closed -$42K 2614
2021
Q4
$42K Sell
13,385
-8,223
-38% -$27.7K ﹤0.01% 525
2021
Q3
$79K Hold
21,608
﹤0.01% 966
2021
Q2
$77K Hold
21,608
﹤0.01% 984
2021
Q1
$83K Buy
+21,608
New +$89.2K ﹤0.01% 964
2020
Q4
Sell
-21,609
Closed -$81K 2455
2020
Q3
$81K Sell
21,609
-11,003
-34% -$46.8K 0.01% 840
2020
Q2
$142K Hold
32,612
0.01% 678
2020
Q1
$124K Sell
32,612
-18
-0.1% -$88 0.01% 666
2019
Q4
$206K Buy
+32,630
New +$192K 0.01% 596

Other funds holding BDSI

Meeder Asset Management's BDSI Position: Q1 2022 in Review

Meeder Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 13,385 shares — an estimated $42K sold.

Meeder Asset Management first reported a position in BDSI in Q4 2019 and held it in 8 quarters. The position peaked at $206K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Meeder Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Meeder Asset Management sold 13,385 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $42K.
  • Meeder Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 8 quarters.
  • Meeder Asset Management's BioDelivery Sciences International, Inc. position peaked at $206K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Meeder Asset Management's 13F filing for Q1 2022, filed 10 May 2022.